With Life Sciences Baltics just three months away, the Scientific American Worldview’s latest international biotechnology rankings have just been released and Lithuania has placed 16th among 54 countries. That’s 19 spots better than 2011 when the country was included in the annual study for the first time.
The 54 countries involved in the study were evaluated in seven categories: productivity, intellectual property protection, intensity, enterprise support, education/workforce, foundations (infrastructure and investment in R&D), and policy and stability. Lithuania was given the highest score possible for its efforts to deploy biotech innovation and was ranked sixth overall in terms of the number of researchers per capita in the medical and health sciences.
Aside from being the top-ranked country in Central and Eastern Europe, Lithuania’s life sciences sector is growing at an average rate of 19% annually. The ambition is to establish the country, with Vilnius at its centre, as Europe’s leading life science hub by 2020.
With all this momentum, it’s fitting to have Vilnius hosting this year’s Life Sciences Baltics conference, taking place on 26-27 September at LITEXPO. The biannual event stands as the only international forum in the Baltic Region for world-class biotechnology, pharmaceutical and medical device experts.
This year, over 1,500 industry professionals from across Europe and the world are expected to take part in the two-day event. Around 40 speakers will lead presentations on a variety of topics as part of the Life Sciences Baltics forum, and some 60 companies will take part in B2B meetings and listen to pitches from invest-ready Life Sciences startups from across the Baltics.
Visit the Life Sciences Baltics website for more information on this year’s event.